Literature DB >> 11193238

Preanalytical variability of biochemical markers of bone turnover.

R Hannon1, R Eastell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193238     DOI: 10.1007/s001980070004

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  51 in total

Review 1.  Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?

Authors:  J J Stepan
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

Review 2.  Bone turnover markers: use in osteoporosis.

Authors:  Kim Naylor; Richard Eastell
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

Review 3.  Bone metabolism markers in sports medicine.

Authors:  Giuseppe Banfi; Giovanni Lombardi; Alessandra Colombini; Giuseppe Lippi
Journal:  Sports Med       Date:  2010-08-01       Impact factor: 11.136

4.  Bone mass and mineral metabolism in HIV+ postmenopausal women.

Authors:  Michael Yin; Jay Dobkin; Karen Brudney; Carolyn Becker; Janis L Zadel; Monica Manandhar; Vicki Addesso; Elizabeth Shane
Journal:  Osteoporos Int       Date:  2005-03-08       Impact factor: 4.507

Review 5.  Bone remodeling markers: assessment of fracture risk and fracture risk reduction.

Authors:  Aubrey Blumsohn
Journal:  Curr Osteoporos Rep       Date:  2003-12       Impact factor: 5.096

6.  Should serial assessment of bone turnover markers be included in fracture risk calculation in elderly women?

Authors:  Samuel D Vasikaran
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-11-18

7.  Socioeconomic status, race, and bone turnover in the Midlife in the US Study.

Authors:  C J Crandall; D Miller-Martinez; G A Greendale; N Binkley; T E Seeman; A S Karlamangla
Journal:  Osteoporos Int       Date:  2011-08-03       Impact factor: 4.507

8.  Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates.

Authors:  Sherri-Ann M Burnett-Bowie; Kenneth Saag; Anthony Sebba; Anne E de Papp; Erluo Chen; Elizabeth Rosenberg; Susan L Greenspan
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

9.  Predicting the timeline to the final menstrual period: the study of women's health across the nation.

Authors:  Gail A Greendale; Shinya Ishii; Mei-Hua Huang; Arun S Karlamangla
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

Review 10.  Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.

Authors:  P Bergmann; J-J Body; S Boonen; Y Boutsen; J-P Devogelaer; S Goemaere; J-M Kaufman; J-Y Reginster; V Gangji
Journal:  Int J Clin Pract       Date:  2009-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.